Last week, Medicover Genetics had the pleasure and honor to attend and present our genetic testing services and laboratory solutions at the 56th conference of the European Society of Human Genetics (ESHG), which took place in Glasgow, Scotland. This year’s conference set a new record for attendance and was a global event, with 5811 registrations and 442 exhibitors from over 90 participating countries.
Over the course of four days, our interdisciplinary team had the opportunity to speak with healthcare professionals from all over the world and inform them about our proprietary portfolio, as well as present our own work in a corporate satellite and during poster presentations.
Our team proudly exhibited eight posters presenting the scientific and medical findings from our laboratories, including molecular characterization of patients with gliomas, accurate and cost-effective alpha-thalassemia detection in an expanded multigene carrier testing panel, and whole exome sequencing in routine diagnostics for patients with developmental delay.
During our fully packed corporate satellite, ‘A scalable technology platform to unlock your laboratory’s genetic testing potential; CE IVD kits, NIPT and liquid biopsy’, our expert speakers shared their experiences and findings on NIPT, our technology transfer platform, CE-IVD genetic assay kits, tumor profiling testing and liquid biopsy.
We would like to thank everyone who stopped by our booth, those who attended our corporate satellite, and our incredible team for their hard work. It was our sincere pleasure to attend such a prominent event in human genetics. This was a great opportunity to present current research and to speak with experts from around the world to discuss different ways we can partner together and help provide optimal genetic testing services that improve people’s health and well-being worldwide.
Read a summary of our poster presentations here.